Aripiprazole and Risperidone in Treatment of Children with Attention Deficit/Hyperactivity Disorder: A Double-Blind Clinical Trial Study

Attention Deficit ◽

Double Blind ◽

Hyperactivity Disorder ◽

Double Blind Clinical Trial

Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2021.0034 ◽

2021 ◽

Author(s):

Margaret D. Weiss ◽

Andrew J. Cutler ◽

Scott H. Kollins ◽

Graeme A.E. Donnelly

Keyword(s):

Clinical Trial ◽

Attention Deficit ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Hyperactivity Disorder ◽

Double Blind Clinical Trial ◽

Open Label Extension ◽

Long Acting

Comparison between the efficacies of Risperidone with Haloperidol in the treatment of attention-deficit hyperactivity disorder (ADHD) among preschoolers: a randomized double-blind clinical trial

Electronic physician ◽

10.19082/2840 ◽

2016 ◽

Vol 8 (9) ◽

pp. 2840-2848 ◽

Cited By ~ 2

Author(s):

Forough Riahi ◽

Ashraf Tashakori ◽

Leila Abdi

Keyword(s):

Clinical Trial ◽

Attention Deficit ◽

Double Blind ◽

Hyperactivity Disorder ◽

Double Blind Clinical Trial

Efficacy and safety of saffron as adjunctive therapy in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled clinical trial

Advances in Integrative Medicine ◽

10.1016/j.aimed.2022.01.002 ◽

2022 ◽

Author(s):

Benyamin Pazoki ◽

Nadia Zandi ◽

Zeinab Assaf ◽

Hossein Sanjari Moghaddam ◽

Arefeh Zeinoddini ◽

...

Keyword(s):

Clinical Trial ◽

Attention Deficit ◽

Adjunctive Therapy ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Selegiline in Comparison with Methylphenidate in Attention Deficit Hyperactivity Disorder Children and Adolescents in a Double-Blind, Randomized Clinical Trial

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2004.14.418 ◽

2004 ◽

Vol 14 (3) ◽

pp. 418-425 ◽

Cited By ~ 22

Author(s):

Mohammad Reza Mohammadi ◽

Ahmad Ghanizadeh ◽

Javad Alaghband-rad ◽

Mahdi Tehranidoost ◽

Bita Mesgarpour ◽

...

Keyword(s):

Clinical Trial ◽

Children And Adolescents ◽

Randomized Clinical Trial ◽

Attention Deficit ◽

Double Blind ◽

Efficacy and safety of tipepidine as adjunctive therapy in children with attention‐deficit/hyperactivity disorder: Randomized, double‐blind, placebo‐controlled clinical trial

Psychiatry and Clinical Neurosciences ◽

10.1111/pcn.12913 ◽

2019 ◽

Vol 73 (11) ◽

pp. 690-696 ◽

Cited By ~ 5

Author(s):

Sara Dehbozorghi ◽

Sayna Bagheri ◽

Kamyar Moradi ◽

Kamyar Shokraee ◽

Mohammad‐Reza Mohammadi ◽

...

Keyword(s):

Clinical Trial ◽

Attention Deficit ◽

Adjunctive Therapy ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Atomoxetine Treatment Strengthens an Anti-Correlated Relationship between Functional Brain Networks in Medication-Naïve Adults with Attention-Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Clinical Trial

The International Journal of Neuropsychopharmacology ◽

10.1093/ijnp/pyv094 ◽

2015 ◽

Vol 19 (3) ◽

pp. pyv094 ◽

Cited By ~ 17

Author(s):

Hsiang-Yuan Lin ◽

Susan Shur-Fen Gau

Keyword(s):

Clinical Trial ◽

Attention Deficit ◽

Double Blind ◽

Double Blind Placebo ◽

Functional Brain ◽

Hyperactivity Disorder ◽

Functional Brain Networks ◽

Atomoxetine Treatment

A randomised, double-blind, placebo-controlled clinical trial of a Compound Herbal Preparation (CHP) in the treatment of children with Attention-Deficit Hyperactivity Disorder (ADHD)

http://isrctn.org/> ◽

10.1186/isrctn10628149 ◽

2012 ◽

Author(s):

Aliza Adar Levine

Keyword(s):

Clinical Trial ◽

Attention Deficit ◽

Herbal Preparation ◽

Double Blind ◽

Double Blind Placebo ◽

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial on Once-Daily Atomoxetine Hydrochloride in Taiwanese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2006.0091 ◽

2007 ◽

Vol 17 (4) ◽

pp. 447-460 ◽

Cited By ~ 42

Author(s):

Susan S.F. Gau ◽

Yu-Shu Huang ◽

Wei-Tsuen Soong ◽

Miao-Chun Chou ◽

Wen-Jiun Chou ◽

...

Keyword(s):

Clinical Trial ◽

Children And Adolescents ◽

Attention Deficit ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo ◽

A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

Biological Psychiatry ◽

10.1016/j.biopsych.2004.11.043 ◽

2005 ◽

Vol 57 (5) ◽

pp. 456-463 ◽

Cited By ~ 228

Author(s):

Thomas Spencer ◽

Joseph Biederman ◽

Timothy Wilens ◽

Robert Doyle ◽

Craig Surman ◽

...

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Attention Deficit ◽

Double Blind ◽

A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Clinical Trial of ORADUR-Methylphenidate for Treating Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2020.0104 ◽

2020 ◽

Author(s):

Yu-Shu Huang ◽

Chin-Bin Yeh ◽

Chin-Hung Chen ◽

Chi-Yung Shang ◽

Susan Shur-Fen Gau

Keyword(s):

Clinical Trial ◽

Children And Adolescents ◽

Attention Deficit ◽

Double Blind ◽

Double Blind Placebo ◽